DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18693
| null |
RWJ-800088
|
257287-15-3
|
CU0FSR29BQ
|
a synthetic PEGylated thrombopoietin (TPO) mimetic (TPOm) peptide with no sequence homology to endogenous | METHOXYPOLYETHYLENEGLYCOL20000-PROPIONYL-L-ISOLEUCYL-L-GLUTAMYL-GLYCYL-L-PROLYL-L-THREONYL-L-LEUCYL-L-ARGINYL-L-GLUTAMINYL-L-2-NAPHTHYLALANYL-L-LEUCYL-L-ALANYL-L-ALANYL-L-ARGINYLSARCOSYL-NE-(METHOXYPOLYETHYLENEGLYCOL20000-PROPIONYL-L-ISOLEUCYL-L-GLUTAMYL | POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-METHOXY-, 1,1'-DIETHER WITH N2,N6-BIS(N-(3-HYDROXY-1-OXOPROPYL)-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-PROLYL-L-THREONYL-L-LEUCYL-L-ARGINYL-L-GLUTAMINYL-3-(2-NAPHTHALENYL)-L-ALANYL-L-LEUCYL-L-ALANYL-L-ALANY | RWJ-800088 (PEGYLATED THROMBOPOIETIN (TPO)-MIMETIC PEPTIDE)
| null |
DB18694
| null |
ISA101b
| null | null |
Peltopepimut-S
| null |
DB18695
| null |
Metelimumab
|
272780-74-2
|
4AR6718OL0
|
Human anti-transforming growth factor beta 1 monoclonal antibody | Immunoglobulin g4, anti-(human transforming growth factor .beta.1 (human monoclonal cat-192 .gamma.4-chain)), disulfide with human monoclonal cat-192 .kappa.-chain, dimer
| null |
DB18696
| null |
CHF5633
| null | null |
Synthetic surfactant comprised of DPPC, POPG Na, synthetic SP-C analogue and synthetic SP-B analogue
| null |
DB18697
| null |
RC88
| null | null | null | null |
DB18698
| null |
Cu-67 sartate
| null |
Y6WKJ2X9X8
|
67Cu sartate | Ucasareotide dasaroxetan Cu-67
| null |
DB18699
| null |
HLX-58
| null | null |
Recombinant anti-claudin 18.2 monoclonal antibody
| null |
DB18700
| null |
TN-201
| null | null |
Native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene
| null |
DB18701
| null |
Chikungunya vaccine (live, attenuated)
| null | null |
Chikungunya vaccine, live | Chikungunya virus LR2006 OPY1 (attenuated strain) antigen
| null |
DB18702
| null |
SHR-A1904
| null | null | null | null |
DB18703
| null |
HRS-1167
| null | null | null | null |
DB18704
| null |
Efbemalenograstim alfa
|
2200269-79-8
|
5UPW5HJW3O
|
Benegrastim | Recombinant dimeric g-csf fusion protein f627 | Rh g-csf fc fusion protein f-627
| null |
DB18705
| null |
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)
| null | null |
Bimervax | SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains
| null |
DB18706
| null |
Emraclidine
|
2170722-84-4
|
J241Y80EEO
|
CVL-231 | Emraclidine | Ethanone, 1-(5,7-dihydro-2,4-dimethyl-6h-pyrrolo(3,4-b)pyridin-6-yl)-2-(1-(2-(trifluoromethyl)-4-pyridinyl)-3-azetidinyl)-
|
DTCZNKWBDTXEBS-UHFFFAOYSA-N
|
DB18707
| null |
AVL-3288
|
917837-54-8
|
VA80VAX4WF
|
(z)-3-(4-chloroanilino)-n-(4-chlorophenyl)-2-(3-methylisoxazol-5-yl)prop-2-enamide | Anvylic-3288 | AVL-3288
|
VMAKIACTLSBBIY-BOPFTXTBSA-N
|
DB18708
| null |
Alogabat
|
2230009-48-8
|
0HPA4GK3UH
|
3-pyridazinecarboxamide, 6-((5-methyl-3-(6-methyl-3-pyridinyl)-4-isoxazolyl)methoxy)-n-(tetrahydro-2h-pyran-4-yl)- | Alogabat
|
ACZCJTHHWMBFKC-UHFFFAOYSA-N
|
DB18709
| null |
Ropsacitinib
|
2127109-84-4
|
HY5SOV7O0Q
|
Cyclobutaneacetonitrile, 3-cyano-1-(4-(6-(1-methyl-1h-pyrazol-4- yl)pyrazolo(1,5-a)pyrazin-4-yl)-1h-pyrazol-1-yl)-, trans- | Ropsacitinib | Trans-3-cyano-1-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrazolo(1,5-a)pyrazin-4-yl)- 1h-pyrazol-1-yl)-cyclobutaneacetonitrile
|
XPLZTJWZDBFWDE-OYOVHJISSA-N
|
DB18710
| null |
ABBV-706
| null | null |
ABBV 706 | ABBV-706 | ABBV706
| null |
DB18711
| null |
taletrectinib
|
1505515-69-4
|
6KLL51GNBG
|
Taletrectinib adipate
|
DORJQZDOULKINH-QNBGGDODSA-N
|
DB18712
| null |
Berdazimer
| null |
B23P7SM943
|
Silsesquioxanes, 3-(2-hydroxy-1-methyl-2-nitrosohydrazinyl)propyl 3-(methylamino)propyl, polymers with silicic acid (h4sio4) tetra-et ester, hydroxy-terminated
| null |
DB18713
| null |
Recombinant stabilized RSV A prefusion F antigen
| null | null |
RSV subgroup A stabilized prefusion F protein
| null |
DB18714
| null |
Recombinant stabilized RSV B prefusion F antigen
| null | null |
RSV subgroup B stabilized prefusion F protein
| null |
DB18715
| null |
Tolebrutinib
|
1971920-73-6
|
8CZ82ZYY9X
|
2h-imidazo(4,5-c)pyridin-2-one, 4-amino-1,3-dihydro-1-((3r)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)- | 4-amino-1,3-dihydro-1-((3r)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-2h-imidazo(4,5-c)pyridin-2-one
|
KOEUOFPEZFUWRF-LJQANCHMSA-N
|
DB18716
| null |
Enmetazobactam
|
1001404-83-6
|
80VUN7L00C
|
(2s,3s,5r)-3-methyl-3-((3-methyltriazol-3-ium-1-yl)methyl)-4,4,7-trioxo-4^6-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate | 1h-1,2,3-triazolium, 3-(((2s,3s,5r)-2-carboxy-3-methyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-3-yl)methyl)-1-methyl-, inner salt
|
HFZITXBUTWITPT-YWVKMMECSA-N
|
DB18717
| null |
Graphite
|
7782-42-5
|
4QQN74LH4O
|
Black lead | C.i. pigment black 10 | Graphites | Mineral carbon | Natural graphite | Plumbago | Stove black
| null |
DB18718
| null |
RVT-3101
| null | null |
RVT-3101
| null |
DB18719
| null |
Tulisokibart
|
2648504-55-4
|
ON09TCS5H3
|
Tulisokibart
| null |
DB18720
| null |
Pemivibart
|
2858673-18-2
|
557S3L3FAP
|
Pemivibart
| null |
DB18721
| null |
Certepetide
|
2580154-02-3
|
7PF4546T2P
|
Ac-Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys-NH2 cyclic (1→9)-disulfide | L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide | N-Acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-L-cysteinamide, cyclic (1→9)-disulfide | S1,S9-cyclo(N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-L-cysteinamide)
| null |
DB18722
| null |
Dilanubicel
| null |
FR89SC8CT4
| null | null |
DB18723
| null |
Cambritaxestat
| null | null | null | null |
DB18724
| null |
rAAV1-CB-hAAT
| null | null |
recombinant adeno-associated virus alpha 1-antitrypsin vector
| null |
DB18725
| null |
Cevidoplenib
|
1703788-21-9
|
3N3H8BX897
|
Methanone, cyclopropyl(5-((4-(4-(((4s)-4-hydroxy-2-isoxazolidinyl)methyl)-3-methyl-1h-pyrazol-1-yl)-2-pyrimidinyl)amino)-1-methyl-1h-indol-3-yl)-
|
YCZUBLQESBVOSH-IBGZPJMESA-N
|
DB18726
| null |
CN-201
| null | null |
recombinant humanized anti-CD3/CD19 bispecific antibody
| null |
DB18727
| null |
HH-009
| null | null |
recombinant human IgG4 monoclonal antibody against FGF19
| null |
DB18728
| null |
Olezarsen
|
2097587-83-0
|
S3RS2SA30L
|
AKCEA-APOCIII-LRX | ALL-P-AMBO-5'-O-(((6-(5-((TRIS(3-(6-(2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYLOXY)HEXYLAMINO)-3-OXOPROPOXYMETHYL))METHYL)AMINO-5-OXOPENTANAMIDO)HEXYL))PHOSPHO)-2'-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3 | DNA, D(P-THIO)((2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-M5C-T-T-G-T-M5C-M5C-A-G-M5C-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETH | IONIS-APOCIII-LRX | ISIS-APOCIII-LRX
| null |
DB18729
| null |
Neoarsphenamine
|
457-60-3
|
O7K7R0O4BG
|
Neosalvarsan | Novarsenol | Sodium p,p'-dihydroxy-m,m'-diaminoarsenobenzene-n-monomethanol sulfoxylate | Sulfoxylic acid, mono(((5-((3-amino-4-hydroxyphenyl)diarsenyl)-2-hydroxyphenyl)amino)methyl) ester, sodium salt (1:1)
|
CXFGBOZIEIIEIH-UHFFFAOYSA-M
|
DB18730
| null |
HTPEP-001
| null | null | null | null |
DB18731
| null |
Pegulicianine
|
2230217-17-9
|
T6HE85WN0Q
| null | null |
DB18732
| null |
Irpagratinib
|
2230974-62-4
|
X46B7JM4A8
|
2-Propenamide, N-[(3S,4S)-3-[[6-(2,6-difluoro-3,5-dimethoxyphenyl)-8-(3-methoxy-3-methyl-1-azetidinyl)pyrido[3,4-d]pyrimidin-2-yl]amino]tetrahydro-2H-pyran-4-yl]- | N-[(3S,4S)-3-[[6-(2,6-Difluoro-3,5-dimethoxyphenyl)-8-(3-methoxy-3-methyl-1-azetidinyl)pyrido[3,4-d]pyrimidin-2-yl]amino]tetrahydro-2H-pyran-4-yl]-2-propenamide
|
PGRHEHZIRYNZDV-FUHWJXTLSA-N
|
DB18733
| null |
BVX-001
| null | null | null | null |
DB18734
| null |
Calpurbatug
|
2635404-72-5
|
F4M5MQK5W7
| null | null |
DB18735
| null |
APL-030
| null | null |
N-(4-((2-aminopyrimidin-5-yl)ethynyl)-3-fluoropyridin-2-yl)-5-chloro-2-methoxypyridine-3-sulfonamide
| null |
DB18736
| null |
Celastrol
|
34157-83-0
|
L8GG98663L
|
24-nor-d:a-friedooleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo- | 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-9,13-dimethyl-2-oxo-, (9.beta.,13.alpha.,14.beta.,20.alpha.)- | Tripterin
|
KQJSQWZMSAGSHN-JJWQIEBTSA-N
|
DB18737
| null |
Procinonide
|
58497-00-0
|
D04S7VLM8Q
|
6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-propionate | Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.alpha)-
|
UBOIMZIXNXGQOH-RTWVSBIPSA-N
|
DB18738
| null |
Ciprocinonide
|
58524-83-7
|
8Y88CP83MK
|
6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-cyclopropanecarboxylate | 6α,9-Difluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-cyclopropanecarboxylate | Pregna-1,4-diene-3,20-dione, 21-((cyclopropylcarbonyl)oxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6.alpha.,11.beta.,16.alpha.)-
|
TZBDXWBBMOEVPI-XBQQDWOSSA-N
|
DB18739
| null |
mRNA-1345
| null | null | null | null |
DB18740
| null |
Nogapendekin alfa
|
1622189-43-8
|
EW92EB4VEN
|
Fusion protein consisting of il-15n72d and il-15rasu/fc | Human interleukin 15 (72-aspartic acid) (human il-15 n72>d isoform) | IL-15N72D | Il-15n72d:il-15rec-su/fc soluble complex i | Inbakicept nogapendekin alfa fusion complex | Superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
| null |
DB18742
| null |
SPG601
| null | null |
(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methylethyl) benzamide
| null |
DB18743
| null |
Bi104
| null | null |
Bi104
| null |
DB18744
| null |
Glecirasib
|
2657613-87-9
|
UP75WH4QKM
| null |
QRRJEUIQLZNPIO-UHFFFAOYSA-N
|
DB18745
| null |
Safusidenib
|
1898206-17-1
|
RCK8KK7SB9
|
(2E)-3-[1-[[5-(1-Fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-2-propenoic acid | 2-Propenoic acid, 3-[1-[[5-(1-fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-, (2E)- | AB-291 free acid | DS-1001 free acid
|
BOOMBLZEOHXPPX-BQYQJAHWSA-N
|
DB18746
| null |
Ocifisertib
|
1338806-73-7
|
TL1UD860AA
|
(1R,2S)-2-[3-[(1E)-2-[4-[[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5′-methoxyspiro[cyclopropane-1,3′-[3H]indol]-2′(1′H)-one | (1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-dimethylmorpholin-4-yl]methyl}phenyl)ethen-1-yl]-1Hindazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one | Cfi-400945 free base | Spiro(cyclopropane-1,3'-(3h)indol)-2'(1'h)-one, 2-(3-((1e)-2-(4-(((2r,6s)-2,6-dimethyl-4-morpholinyl)methyl)phenyl)ethenyl)-1h-indazol-6-yl)-5'-methoxy-, (1r,2s)-
|
DADASRPKWOGKCU-FVTQAUBDSA-N
|
DB18747
| null |
MS1901
| null | null |
Thrombin-preconditioned allogeneic Wharton's Jelly-derived mesenchymal stem cells
| null |
DB18748
| null |
Lixumistat
|
1422365-93-2
| null | null | null |
DB18749
| null |
Soquelitinib
|
2226636-04-8
|
6I5H17AN3I
|
Cyclopropanecarboxamide, N-[5-[[5-[[(3R)-hexahydro-3-methyl-4-(1-oxo-2-propen-1-yl)-1H-1,4-diazepin-1-yl]carbonyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]- | N-{5-[(5-{[(3R)-4-(prop-2-enoyl)-3-methyl-1,4-diazepan-1-yl]carbonyl}-4-methoxy-2-methylphenyl)sulfanyl]-1,3-thiazol-2-yl}cyclopropanecarboxamide
|
KNCWSXRTKLTULH-MRXNPFEDSA-N
|
DB18750
| null |
Influenza A Virus A/California/122/2022 SAN-022 (H3N2) antigen (formaldehyde inactivated)
| null | null | null | null |
DB18751
| null |
Donidalorsen
|
2304692-48-4
|
ZD4D8M32TL
|
DNA, D((2'-O-(2-METHOXYETHYL))M5RU-SP-(2'-O-(2-METHOXYETHYL))RG-SP-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RA-SP-G-SP-T-SP-M5C-SP-T-SP-M5C-SP-T-SP-T-SP-G-SP-G-SP-M5C-SP-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL)
| null |
DB18752
| null |
Indotecan
|
915303-09-2
|
BTA69L5M8D
|
5h-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6h)-dione, 2,3-dimethoxy-6-(3-(4-morpholinyl)propyl)-
|
FMFIFGLHVOZDEL-UHFFFAOYSA-N
|
DB18753
| null |
Sonrotoclax
|
2383086-06-2
|
30R67U9KYS
|
N-[4-({[(1r,4r)-4-hydroxy-4-methylcyclohexyl]methyl}amino)-3- nitrobenzene-1-sulfonyl]-4-(2-{(2S)-2-[2-(propan-2-yl)phenyl]pyrrolidin- 1-yl}-7-azaspiro[3.5]nonan-7-yl)-2-[(1H-pyrrolo[2,3-b]pyridin-5- yl)oxy]benzamide
|
ZQTKOYMWCCSKON-XKXNWSITSA-N
|
DB18754
| null |
Excindogen
| null | null | null | null |
DB18755
| null |
Monepantel
|
887148-69-8
|
82MA79VJ33
|
Benzamide, n-((1s)-1-cyano-2-(5-cyano-2-(trifluoromethyl)phenoxy)-1-methylethyl)-4-((trifluoromethyl)thio)- | Monepantel component of zolvix | N-(2-cyano-1-((2s)-5-cyano-2-(trifluoromethyl)phenoxy)propan-2-yl)-4-(trifluoromethylsulfanyl)benzamide | Zolvix component monepantel
|
WTERNLDOAPYGJD-SFHVURJKSA-N
|
DB18756
| null |
Diaminopyrimidine oxide
|
74638-76-9
|
1756681479
|
2,4-diaminopyrimidine 3-n-oxide | 2,4-pyrimidinediamine, 3-oxide | Aminexil | Kopexil | Mexoryl sag
|
SGHQFNHCCOBUKB-UHFFFAOYSA-N
|
DB18757
| null |
CL-315555
|
133513-12-9
|
WU713D62N9
|
23h,25h-benzo(b)porphine-9,13-dipropanoic acid, 18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-, 9-monomethyl ester, trans- | Bpd-ma(sub c) | Verteporfin c isomer | Verteporfin-mac
|
YTZALCGQUPRCGW-MXVXOLGGSA-N
|
DB18758
| null |
CL-315585
|
142878-05-5
|
54JVX48G8K
|
23h,25h-benzo(b)porphine-9,13-dipropanoic acid, 18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-, .alpha.13-methyl ester, trans- | 23h,25h-benzo(b)porphine-9,13-dipropanoic acid, 18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-, 13-monomethyl ester, trans- | Bpd-ma(sub d) | Verteporfin d isomer | Verteporfin-mad
|
CABKTHJNHVBKCC-MXVXOLGGSA-N
|
DB18759
| null |
APD-209
|
1261156-82-4
|
VBU6DO3S24
|
.alpha.-neuraminic acid, n-acetyl-2-o-(7,26-dioxo-10,13,16,19,22-pentaoxa-6,25-diazapentaconta-35,37-diyn-1-yl)-
|
VRJMVFQLUBTBKF-HBJHFNNESA-N
|
DB18760
| null |
11C-AMT
|
157399-98-9
|
0T6U1DP1TQ
|
.alpha.-methyl-l-tryptophan C-11 | L-tryptophan, .alpha.-(methyl-11c)-
|
ZTTWHZHBPDYSQB-ZYZCRDMLSA-N
|
DB18761
| null |
Zotarolimus
|
221877-54-9
|
H4GXR80IZE
|
Zotarolimus
|
CGTADGCBEXYWNE-JUKNQOCSSA-N
|
DB18762
| null |
Zongertinib
|
2728667-27-2
|
DRH7R67UVL
|
Zongertinib
|
YSGNGFPNTLERCR-UHFFFAOYSA-N
|
DB18763
| null |
Zipalertinib
|
1661854-97-2
|
T4YMU8TW9H
|
Zipalertinib
|
MKCYPWYURWOKST-INIZCTEOSA-N
|
DB18764
| null |
Zamtocabtagene autoleucel
| null |
NT3BAN5MDV
|
Autologous anti-CD20/CD19-targeting tandem CAR T cells MB-CART2019.1 | Autologous pLTG1497-transduced CAR T cells MB-CART2019.1
| null |
DB18765
| null |
Zamaporvint
|
1900754-56-4
|
M56M7CHN8E
|
1h-imidazole-1-acetamide, 5-methyl-n-(5-(2-pyrazinyl)-2-pyridinyl)-4-(2-(trifluoromethyl)-4-pyridinyl)- | 5-methyl-n-(5-(2-pyrazinyl)-2-pyridinyl)-4-(2-(trifluoromethyl)-4-pyridinyl)-1h-imidazole-1-acetamide | Zamaporvint
|
QMLOYDPILBUVBV-UHFFFAOYSA-N
|
DB18766
| null |
Zalunfiban
|
1448313-27-6
|
5XQC91CO1F
|
2-amino-n-(4-(5-oxo-7-(piperazin-1-yl)-5h-(1,3,4)thiadiazolo(3,2-a)pyrimidin-2-yl)pyridin-2-yl)acetamide | Acetamide, 2-amino-n-(5-(5-oxo-7-(1-piperazinyl)-5h-1,3,4-thiadiazolo(3,2- a)pyrimidin-2-yl)-3-pyridinyl)- | Zalunfiban
|
LTVKZVGAALCRFW-UHFFFAOYSA-N
|
DB18767
| null |
Zabedosertib
|
1931994-81-8
|
N1GRK350ZM
|
2-pyridinecarboxamide, n-(6-(1-hydroxy-1-methylethyl)-2-(2-(methylsulfonyl)ethyl)-2h-indazol-5-yl)-6-(trifluoromethyl)- | N-(6-(1-hydroxy-1-methylethyl)-2-(2-(methylsulfonyl)ethyl)-2h-indazol-5-yl)-6-(trifluoromethyl)-2-pyridinecarboxamide | N-(6-(2-hydroxypropan-2-yl)-2-(2-(methanesulfonyl)ethyl)- 2h-indazol-5-yl)-6-(trifluoromethyl)pyridine-2- carboxamide
|
OQAMEEFUUFJZRS-UHFFFAOYSA-N
|
DB18768
| null |
Yimitasvir
|
1959593-23-7
|
K465JAH79P
| null |
CMLNPOWEANUBIB-XIGHHNHFSA-N
|
DB18769
| null |
Gemlapodect
|
1380329-87-2
|
RF3JGD64ZU
|
Gemlapodect
|
MMCSMWHWVGGCGL-UHFFFAOYSA-N
|
DB18770
| null |
Gartisertib
|
1613191-99-3
|
7OM98IUD1O
|
2-amino-6-fluoro-n-(5-fluoro-4-(4-((4-(oxetan-3-yl)piperazin-1-yl)carbonyl)-1-piperidyl)-3-pyridyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide | Gartisertib | Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 2-amino-6-fluoro-n-(5-fluoro-4-(4-((4-(3-oxetanyl)-1-piperazinyl)carbonyl)-1-piperidinyl)-3-pyridinyl)-
|
QAYHKBLKSXWOEO-UHFFFAOYSA-N
|
DB18771
| null |
Frunexian
|
1803270-60-1
|
BKE5CVP3FS
|
Frunexian
|
NYPSZHLKEMYZKK-XFJVYGCCSA-N
|
DB18772
| null |
Fosciclopirox
|
1380539-06-9
|
G8FR269QPQ
|
((6-cyclohexyl-4-methyl-2-oxopyridin-1(2h)-yl)oxy)methyl dihydrogen phosphate | 2(1h)-pyridinone, 6-cyclohexyl-4-methyl-1-((phosphonooxy)methoxy)- | 6-cyclohexyl-4-methyl-1-((phosphonooxy)methoxy)-2(1h)-pyridinone | Ciclopirox-pom
|
NTKBXPWLNROYPE-UHFFFAOYSA-N
|
DB18773
| null |
Flurpiridaz F-18
|
863887-89-2
|
TY3V24C029
|
2-tert-butyl-4-chloro-5-((4-((2-(18f)fluoroethoxy)methyl)phenyl)methoxy)pyridazin-3(2h)-one | 2-tert-butyl-4-chloro-5-[[4-(2-(18F)fluoranylethoxymethyl)phenyl]methoxy]pyridazin-3-one | 3(2h)-pyridazinone, 4-chloro-2-(1,1-dimethylethyl)-5-((4-((2-(fluoro-(sup 18)f)ethoxy)methyl)phenyl)methoxy)- | 3(2h)-pyridazinone, 4-chloro-2-(1,1-dimethylethyl)-5-((4-((2-(fluoro-18f)ethoxy)methyl)phenyl)methoxy)- | 4-chloro-2-(1,1-dimethylethyl)-5-((4-((2-((sup 18)f)fluoroethoxy)methyl)phenyl) methoxy)pyridazin-3(2h)-one | Flurpiridaz (18f) | flurpiridaz (¹⁸F) | Flurpiridaz f 18 | Flurpiridaz, F-18
|
RMXZKEPDYBTFOS-LRFGSCOBSA-N
|
DB18774
| null |
Ficonalkib
|
2233574-95-1
|
8EPZ3U4PSS
| null |
LDTJJGGYLQQRSP-UHFFFAOYSA-N
|
DB18775
| null |
Evenamide
|
1092977-61-1
|
ON5S6N53JS
|
2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethylacetamide | Acetamide, 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethyl-
|
GRHBODILPPXVKN-UHFFFAOYSA-N
|
DB18776
| null |
(R)-etodolac
|
87226-41-3
|
Y1RAH31T6K
|
(-)-(r)-etodolac | (-)-etodolac | (1r)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid | Etodolac, (-)- | Etodolac, (R)- | Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (1r)- | Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (r)- | R-etodolac
|
NNYBQONXHNTVIJ-QGZVFWFLSA-N
|
DB18777
| null |
Sacituzumab tirumotecan
|
2768350-77-0
|
3DV5TD1VL3
| null | null |
DB18778
| null |
Lusvertikimab
|
2375835-91-7
|
H1V41MWX63
|
Lusvertikimab
| null |
DB18779
| null |
Vepafestinib
|
2129515-96-2
|
LF333FK2V5
| null |
SFXVRNLGOSAWIV-UHFFFAOYSA-N
|
DB18780
| null |
XP-102
|
1392429-79-6
|
V32TR55QP9
| null |
AEJACXAFHXBVHF-UHFFFAOYSA-N
|
DB18781
| null |
Vutiglabridin
|
1800188-47-9
|
7AWD9J49UP
|
Vutiglabridin
|
IUXJXQLTUMGHHL-UHFFFAOYSA-N
|
DB18782
| null |
Vonafexor
|
1192171-69-9
|
XG6DG6A1UN
|
2-benzofurancarboxylic acid, 4-chloro-5-(4-((2,6-dichlorophenyl)sulfonyl)-1-piperazinyl)- | Vonafexor
|
XLGQSYUNOIJBNR-UHFFFAOYSA-N
|
DB18783
| null |
Velmupressin
|
1647119-61-6
|
XXP2BHA72W
|
L-prolinamide, 4-chloro-n-(4-mercapto-1-oxobutyl)-l-phenylalanyl-3-(2-thienyl)-l-alanyl-l-valyl-l-asparaginyl-l-cysteinyl-n-(4-((aminoiminomethyl)amino)butyl)-, cyclic (1->5)-thioether | Velmupressin
|
VXHQBKSIDHVNIG-JWPGHGORSA-N
|
DB18784
| null |
Vebicorvir
|
2090064-66-5
|
16F6055SMG
|
5,5,11-trioxo-n-((2-(trifluoromethyl)-1,3-thiazol-5-yl)methyl)-10,11-dihydro-5h- 5.lambda.6-dibenzo(b,f)(1,4)thiazepine-8-carboxamide | Dibenzo(b,f)(1,4)thiazepine-8-carboxamide, 10,11-dihydro-11-oxo-n-((2-(trifluoromethyl)-5-thiazolyl)methyl)-, 5,5-dioxide | Vebicorvir
|
LBJVBJYMZKEREY-UHFFFAOYSA-N
|
DB18785
| null |
Varoglutamstat
|
1276021-65-8
|
E3DSH8LL4L
|
(5s)-1-(1h-benzimidazol-5-yl)-5-(4- propoxyphenyl)imidazolidin-2-one | (s)-1-(1h-benzimidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one | 2-imidazolidinone, 1-(1h-benzimidazol-6-yl)-5-(4-propoxyphenyl)-, (5s)- | Varoglutamstat
|
XHIKZWOEFZENIX-GOSISDBHSA-N
|
DB18786
| null |
APX-3330
|
136164-66-4
|
11267UI968
|
APE1/REF-1 redox inhibitor APX3300 | Undecanoic acid, 2-((4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene)-, (2e)-
|
AALSSIXXBDPENJ-FYWRMAATSA-N
|
DB18787
| null |
Ulonivirine
|
1591823-76-5
|
4NS011EGKZ
|
Ulonivirine
|
YSFHLBYWQCLYIY-UHFFFAOYSA-N
|
DB18788
| null |
Ulixacaltamide
|
1199236-64-0
|
QT2PJH89C3
|
Ulixacaltamide
|
JOCLITFYIMJMNK-UHFFFAOYSA-N
|
DB18789
| null |
Ulevostinag
|
2082743-96-0
|
CKP8AS5W73
|
Cyclo((p3'r,2's)-2'-deoxy-2'-fluoro-p-thioadenylyl-(3'->5')-(p2'r)- 3'-deoxy-3'-fluoro-p-thioguanylyl-(2'->5')) | Guanosine, (p(r))-2'-deoxy-2'-fluoro-5'-o-((r)-hydroxymercaptophosphinyl)-p-thio-.beta.-d-arabino-adenylyl-(3'->5')-3'-deoxy-3'-fluoro-, cyclic nucleotide
|
YSUIQYOGTINQIN-CLMXYZJCSA-N
|
DB18790
| null |
Tuvusertib
| null | null |
2-amino-6-fluoro-N-[5-fluoro-4-(1-methyl-1H-imidazol-5-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | Tuvusertib
| null |
DB18791
| null |
Tunlametinib
|
1801756-06-8
|
IF25NR1PV3
|
4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-n-(2-hydroxyethoxy)-6-benzothiazolecarboxamide | 6-benzothiazolecarboxamide, 4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-n-(2-hydroxyethoxy)- | Tunlametinib
|
UFZJUVFSSINETF-UHFFFAOYSA-N
|
DB18792
| null |
Treprostinil palmitil
|
1706528-83-7
|
8GJK87S89F
|
Acetic acid, 2-(((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)- 3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, hexadecyl ester | Hexadecyl 2-(((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta(b)naphthalen-5-yl)oxy)acetate | Hexadecyl treprostinil | Treprostinil hexadecyl ester
|
XOKCXRVJBBLBSX-HDMCCQRMSA-N
|
DB18793
| null |
Trelanserin
|
189003-92-7
|
QUD44MBL5S
|
Pyridin-4-yl)piperazin-1-yl)ethyl)-1,2-dihydroquinolin-1-yl)acetamide
|
JDLYOFUDIKMYBL-UHFFFAOYSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.